Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 4
Treatment-assignment count: 0
Stratification count: 0
Trial Selection Rising
NTRK fusion
solid tumor basket · Therapy Not Normalized
NTRK fusion is flagged as trial selection rising because public trials show inclusion required evidence in 7 contexts. FDA CDx context should be reviewed manually.
Threshold snippets
Fragmentation view
Threshold count: 1
Common snippets: BRAF V600E
Threshold label: Low
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Not Found
CDx maturity score: 1/5
Confidence: High
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT04901806 | https://clinicaltrials.gov/study/NCT02650401 | https://clinicaltrials.gov/study/NCT06790589 | https://clinicaltrials.gov/study/NCT03155620 | https://clinicaltrials.gov/study/NCT03375437 | https://clinicaltrials.gov/study/NCT04094610 | https://clinicaltrials.gov/study/NCT04671849